Key result
Transcatheter aortic valve implantation improved quality of life and increased walking distance test distance from a median of 200 m to 325 m at 12 months in high-risk patients with severe aortic stenosis.
Why the study?
Does transcatheter aortic valve implantation improve quality of life in elderly high-risk patients with symptomatic severe aortic stenosis?
Observational (n=40)
No
Does transcatheter aortic valve implantation improve quality of life in elderly high-risk patients with symptomatic severe aortic stenosis?
Answers are grounded in this paper and cite their sources.
TAVI significantly improves quality of life and functional capacity up to 12 months in elderly high-risk patients with severe aortic stenosis.
BACKGROUND: Transcatheter aortic valve implantation (TAVI) is a treatment option for elderly high-risk patients with symptomatic severe aortic stenosis. Improvement of quality of life (QoL) is a relevant issue in this group of patients. AIM: To assess changes in QoL after TAVI. METHODS: Forty patients who underwent TAVI in our institution were included in this QoL study. All subjects were screened for TAVI in a standard fashion, including QoL assessment with the EQoL (EQ-5D-3L). The pre- and postprocedural scores obtained up to a 12-month follow-up were assessed. RESULTS: Median of logistic EuroScore I was 21.5% (13.5-26.75%), and Society of Thoracic Surgeons score was 5.5% (4.0-10.75%). Comparison of baseline values with follow-up data at one, six and 12 months after TAVI showed significant improvement of QoL (p < 0.001). Visual Analogue Scale score (VAS score) was assessed. There was an incremental increase in VAS score during follow-up (p < 0.001). Median of six-minute walk test distance at baseline was 200 m (IQR 150-300) and 325 m (IQR 250-400) 12 months after TAVI (p < 0.001). CONCLUSIONS: TAVI provides improved QoL and effectively relieves symptoms.
No takes yet. Share an insight, caveat, or question.
Kleczyński et al. (2014) conducted an observational in Symptomatic severe aortic stenosis (n=40). Transcatheter aortic valve implantation (TAVI) was evaluated on Quality of life assessed by EQ-5D-3L questionnaire (p=<0.001). Transcatheter aortic valve implantation improved quality of life and increased walking distance test distance from a median of 200 m to 325 m at 12 months in high-risk patients with severe aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: